vs

Side-by-side financial comparison of Intercure Ltd. (INCR) and Pioneer Bancorp, Inc. (PBFS). Click either name above to swap in a different company.

Intercure Ltd. is the larger business by last-quarter revenue ($35.1M vs $25.0M, roughly 1.4× Pioneer Bancorp, Inc.).

Intercure Ltd. is a biopharmaceutical company that develops, manufactures and sells prescription and over-the-counter therapeutic products for chronic respiratory, cardiovascular and metabolic conditions. Its core markets are North America, the EU and Israel, serving consumer healthcare and prescription patient segments.

Pioneer Bancorp, Inc. (MD) is a bank holding company operating as the parent entity of Pioneer Bank. It provides a full suite of retail and commercial banking products and services, including deposit accounts, residential and commercial mortgages, consumer loans, and small business financing, primarily serving individual and corporate customers across local communities in Maryland, U.S.

INCR vs PBFS — Head-to-Head

Bigger by revenue
INCR
INCR
1.4× larger
INCR
$35.1M
$25.0M
PBFS

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
INCR
INCR
PBFS
PBFS
Revenue
$35.1M
$25.0M
Net Profit
$3.7M
Gross Margin
29.4%
Operating Margin
4.4%
21.3%
Net Margin
82.1%
Revenue YoY
Net Profit YoY
EPS (diluted)
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INCR
INCR
PBFS
PBFS
Q4 25
$25.0M
Q3 25
$24.0M
Q2 25
$35.1M
$24.4M
Q1 25
$22.8M
Q3 24
$22.0M
Q2 24
$20.9M
Q1 24
$21.6M
Q4 23
$4.2M
Net Profit
INCR
INCR
PBFS
PBFS
Q4 25
$3.7M
Q3 25
$4.3M
Q2 25
$6.5M
Q1 25
$5.8M
Q3 24
$6.3M
Q2 24
$3.9M
Q1 24
$4.7M
Q4 23
$3.2M
Gross Margin
INCR
INCR
PBFS
PBFS
Q4 25
Q3 25
Q2 25
29.4%
Q1 25
Q3 24
Q2 24
Q1 24
Q4 23
Operating Margin
INCR
INCR
PBFS
PBFS
Q4 25
21.3%
Q3 25
23.4%
Q2 25
4.4%
33.3%
Q1 25
32.5%
Q3 24
37.2%
Q2 24
24.1%
Q1 24
28.1%
Q4 23
96.1%
Net Margin
INCR
INCR
PBFS
PBFS
Q4 25
82.1%
Q3 25
18.0%
Q2 25
26.4%
Q1 25
25.3%
Q3 24
28.7%
Q2 24
107.4%
Q1 24
21.9%
Q4 23
76.4%
EPS (diluted)
INCR
INCR
PBFS
PBFS
Q4 25
$0.16
Q3 25
$0.18
Q2 25
$0.26
Q1 25
$0.23
Q3 24
$0.25
Q2 24
$0.15
Q1 24
$0.19
Q4 23
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INCR
INCR
PBFS
PBFS
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$323.9M
Total Assets
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Stockholders' Equity
INCR
INCR
PBFS
PBFS
Q4 25
$323.9M
Q3 25
$314.2M
Q2 25
$314.2M
Q1 25
$310.7M
Q3 24
$303.8M
Q2 24
$296.5M
Q1 24
$289.0M
Q4 23
$283.8M
Total Assets
INCR
INCR
PBFS
PBFS
Q4 25
$2.2B
Q3 25
$2.2B
Q2 25
$2.1B
Q1 25
$2.1B
Q3 24
$2.0B
Q2 24
Q1 24
$2.0B
Q4 23
$1.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INCR
INCR
PBFS
PBFS
Operating Cash FlowLast quarter
$11.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.97×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INCR
INCR
PBFS
PBFS
Q4 25
$11.1M
Q3 25
$3.9M
Q2 25
$5.1M
Q1 25
$-3.5M
Q3 24
$1.9M
Q2 24
$9.0M
Q1 24
$3.3M
Q4 23
$-943.0K
Cash Conversion
INCR
INCR
PBFS
PBFS
Q4 25
2.97×
Q3 25
0.90×
Q2 25
0.78×
Q1 25
-0.61×
Q3 24
0.30×
Q2 24
2.30×
Q1 24
0.70×
Q4 23
-0.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons